New metabolic vulnerabilities of subsets of triple-negative breast cancer discovered
Researchers have identified a metabolic enzyme and pathway in some triple-negative breast cancer (TNBC) patients, which they hope could serve […]
» Read morenohealthproblemsnews.com
Home »
Researchers have identified a metabolic enzyme and pathway in some triple-negative breast cancer (TNBC) patients, which they hope could serve […] Liquid biopsy can help to identify breast cancer patients with a poor prognosis earlier and more accurately than before, a […] Elizabeth Hurley first aligned herself with Estée Lauder’s Pink Ribbon campaign in 1995, after she was approached by Evelyn Lauder […] Morphle Labs makes its ceremonial 101st scanner for NIH’s National Cancer Institute. It customized the scanner to fit the research […] NEW YORK (Reuters Health) – In women with lymph node-negative, estrogen receptor-positive/ERBB2-negative breast cancer, tumor size and grade were significantly […] Results were released this week on a new treatment with the potential to improve the outcomes for patients with hereditary […] One of Europe’s largest cancer centers, The Christie NHS Foundation Trust, has become the first in the country to provide […] Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with a high fatality rate. Currently, chemotherapy is the […] Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Last year, cancer screening programs around […] While social media sites have been criticized for helping spread COVID misinformation and conspiracy theories, Wikipedia strives to be accurate […]
New metabolic vulnerabilities of subsets of triple-negative breast cancer discovered
Liquid biopsy enables early, accurate identification of breast cancer patients with poor prognosis
What Elizabeth Hurley Has Learned In Nearly Three Decades of Breast Cancer Activism
Morphle manufactures its 101st slide scanner for NIH’s NCI
Tumor Size, Grade Tied to Long-Term Survival in Selected Breast Cancer Patients
New treatment may improve outcomes for patients with BRCA mutation-associated early breast cancer
The Christie NHS Foundation Trust first to offer treatment in cancer patients’ homes
CityU researchers identify super-enhancers that stimulate the activity of breast cancer genes
Cancer Screening Stopped by Pandemic: Repercussions to Come?
How Wikipedia Fought COVID Misinformation